Rocket Lab Corp. (RKLB)
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-14
$62.55-0.64%
Close 2026-09-14 · 1-day change
NASDAQIndustrialsAerospace & DefenseSnapshot 2026-09-14
Research Workspace
Put RKLB beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 53% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 19%, softest on free-cash-flow margins.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 4% on a typical day and fell roughly 61% in its worst 12-month stretch.
View RiskRocket Lab's growth depends on its ability to expand revenue and backlog. The company recently secured a $397 million Space Force contract, boosting its revenue outlook. It trades at 52× sales, while peers trade at 3×. This suggests the price reflects less growth than expected. If Rocket Lab cuts guidance, it could face a significant decline. The valuation read shows peer multiples imply a price about 45% above where it trades. Our read is provisional.
Trailing returns as of 2026-09-14. RKLB is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 19 analysts currently covering RKLB (as of Sep 2026).
Based on 9 Wall Street analysts offering 12-month price targets for RKLB in the last 4 months.
Continue this research
Compare RKLB with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| RKLB Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 1 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put RKLB next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Complete acquisition of Iridium Communications
Financing confirms commitment to Iridium acquisition.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $62.55
The last 12 months of price, then the range of analyst 12-month targets from today’s $62.55.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Complete acquisition of Iridium Communications
Optimism around Iridium deal supports growth objectives.
Advances: Complete acquisition of Iridium Communications
Optimism around Iridium deal supports growth objectives.
Positive analyst rating may boost investor confidence.
Advances: Achieve record revenue growth and backlog expansion
Backlog strength supports revenue growth objective.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Neutron risk could hinder product development timeline.
Threatens: Develop and launch Neutron medium-lift reusable rocket
Delays in Neutron development could hinder growth objectives.
CFO selling shares raises concerns about leadership confidence.
